GlassScriptPhysician profile
Mario Theliard
NPI 1669804720
$2,873.88
in general payments reported to CMS, 2019-2025
17 companies · $87.50 in 2025
The $87.50 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $237 · 2021: $623 · 2022: $534 · 2023: $228 · 2024: $284 · 2025: $87.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $664.92 | 2019-2024 | Descovy |
| Janssen Products, LP | $568.93 | 2019-2022 | |
| Janssen Biotech, INC. | $501.82 | 2019-2023 | Symtuza |
| Viiv Healthcare Company | $410.45 | 2021-2025 | Cabenuva, Dovato, Apretude |
| Lilly USA, LLC | $241.05 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $116.04 | 2019-2024 | Pifeltro, Delstrigo |
| Exact Sciences Corporation | $72.07 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $56.77 | 2019-2023 | Shingrix |
| Amgen INC. | $53.46 | 2019-2024 | Repatha |
| Novo Nordisk INC | $48.17 | 2021-2022 | |
| Abbvie INC. | $33.01 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Sanofi Pasteur INC. | $17.31 | 2019 | |
| Hologic Sales and Service, LLC | $16.30 | 2023 | Thinprep 2000 Processor, Aptima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.76 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.86 | 2022 | |
| Theratechnologies INC. | $14.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Theliard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.